LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT02652871 · COMPLETED
Trial details
- NCT number
- NCT02652871
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-09
- Primary completion
- 2019-07-16
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.